Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Comparative study of the pharmacodynamic parameters and pharmacodynamic equivalence (bioequivalence) of drug Antareit 800 mg/10 ml oral suspension and drug Riopan 800 mg chewable tablets in healthy volunteers.

NCT Number	NCT06098742
Lead Sponsor	Valenta Pharm JSC
Conditions	Heartburn, Acid-dependent Diseases of the Gastrointestinal Tract, Symptomatic Treatment of Gastric and Duodenal Ulcers
Enrollment	50 participants
Start Date	2024-04-25
Primary Completion	2024-10-20 (estimated)
Study Completion	2025-09-20 (estimated)
Updated on ClinicalTrials.gov	2024-07-22